Company filings profile · CIK 0001835268
Connect Biopharma Holdings Ltd — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for Connect Biopharma Holdings Ltd (CNTB): 6 filings in the last 90 days vs 12 in the prior 90 (filing-velocity cooling ↓ · 0.5×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 1, 2026. Source-linked, daily-refreshed.
Material 8-K events — Connect Biopharma Holdings Ltd
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Sep 30, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 12, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 12, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 23, 2026 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 31, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Dec 23, 2025 | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
Watch Connect Biopharma Holdings Ltd automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Sep 30, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Sep 15, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 12, 2026 | 10-Q | 10-Q | ↗ |
| Aug 12, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Jul 1, 2026 | 4 | FORM 4 | ↗ |
| Jul 1, 2026 | 4 | FORM 4 | ↗ |
| Jun 2, 2026 | 4 | 4 | ↗ |
| Jun 1, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| May 28, 2026 | CORRESP | ↗ | |
| May 22, 2026 | UPLOAD | ↗ | |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 15, 2026 | F-3 | F-3 | ↗ |
| May 12, 2026 | 10-Q | 10-Q | ↗ |
| May 12, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 23, 2026 | 8-K | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Apr 14, 2026 | SCHEDULE 13G | ↗ | |
| Apr 2, 2026 | 4 | FORM 4 | ↗ |
| Apr 2, 2026 | 4 | FORM 4 | ↗ |
| Apr 1, 2026 | 4 | 4 | ↗ |
| Apr 1, 2026 | SCHEDULE 13D/A | ↗ | |
| Mar 31, 2026 | 10-K | 10-K | ↗ |
| Mar 31, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 30, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | ↗ |
| Mar 18, 2026 | 3 | 3 | ↗ |
| Mar 16, 2026 | 3 | FORM 3 | ↗ |
| Mar 16, 2026 | 3 | FORM 3 | ↗ |
| Mar 16, 2026 | 3 | FORM 3 | ↗ |
| Mar 16, 2026 | 3 | FORM 3 | ↗ |
| Mar 16, 2026 | 3 | FORM 3 | ↗ |
| Mar 16, 2026 | 3 | FORM 3 | ↗ |
| Mar 16, 2026 | 3 | FORM 3 | ↗ |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G | ↗ | |
| Dec 23, 2025 | 8-K | Departure/Election of Directors or Officers; Financial Statements and Exhibits | ↗ |
| Nov 28, 2025 | SCHEDULE 13G/A | ↗ | |
| Nov 26, 2025 | SCHEDULE 13D/A | ↗ | |
| Nov 24, 2025 | 144 | ↗ |